{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T20:33:37Z","timestamp":1774902817154,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.arcmed.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T04:53:04Z","timestamp":1663217584000},"page":"550-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["MiR-373\/miR-520s-CD44 Axis Significantly Inhibits the Growth and Invasion of Human Glioblastoma Cells"],"prefix":"10.1016","volume":"53","author":[{"given":"Shuo","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2112-5147","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2022.08.003_bib0001","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and molecular epidemiology of adult diffuse glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0003","first-page":"4785","article-title":"Whether CD44 is an applicable marker for glioma stem cells","volume":"9","author":"Wang","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0004","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1074\/jbc.M607219200","article-title":"Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands","volume":"282","author":"Napier","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01052619","article-title":"Expression of variant CD44 epitopes in human astrocytic brain tumors","volume":"26","author":"Eibl","year":"1995","journal-title":"J Neurooncol"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0006","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.celrep.2017.07.049","article-title":"CD44 Interacts with HIF-2alpha to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells","volume":"20","author":"Johansson","year":"2017","journal-title":"Cell reports"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0007","first-page":"3698","article-title":"Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma","volume":"18","author":"Dong","year":"2019","journal-title":"Oncology letters"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0008","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-019-03288-8","article-title":"Overexpression of CD44 is associated with a poor prognosis in grade II\/III gliomas","volume":"145","author":"Hou","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0009","article-title":"Expression of CD44 and the survival in glioma: a meta-analysis","volume":"40","author":"Wu","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.omto.2020.03.012","article-title":"Identification of the Combinatorial Effect of miRNA Family Regulatory Network in Different Growth Patterns of GC","volume":"17","author":"Cheng","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.celrep.2016.12.024","article-title":"Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level","volume":"18","author":"Klank","year":"2017","journal-title":"Cell reports"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.15957","article-title":"Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma","volume":"24","author":"Peng","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0013","doi-asserted-by":"crossref","first-page":"353","DOI":"10.18388\/abp.2015_1072","article-title":"miRNA Multiplayers in glioma. From bench to bedside","volume":"62","author":"Rolle","year":"2015","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-018-0812-2","article-title":"New insights into long noncoding RNAs and their roles in glioma","volume":"17","author":"Peng","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0015","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10571-016-0338-3","article-title":"miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2","volume":"36","author":"Wei","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0016","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0017","article-title":"[The 2021 WHO classification of tumours of the central nervous system]","author":"Figarella-Branger","year":"2021","journal-title":"Ann Pathol"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0018","doi-asserted-by":"crossref","first-page":"eaay5947","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sjostedt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0019","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12967-018-1582-8","article-title":"Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer","volume":"16","author":"Cheng","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0020","article-title":"Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion","volume":"10","author":"Chen","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109369","article-title":"Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence","volume":"118","author":"Zhou","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0023","first-page":"29","article-title":"New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression","volume":"1825","author":"Bauvois","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0024","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biopha.2017.07.010","article-title":"Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells","volume":"93","author":"Gu","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0025","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2016.05.012","article-title":"The role of CD44 in glioblastoma multiforme","volume":"34","author":"Mooney","year":"2016","journal-title":"J Clin Neurosc"},{"issue":"Pt A","key":"10.1016\/j.arcmed.2022.08.003_bib0027","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biocel.2016.09.009","article-title":"CD44: More than a mere stem cell marker","volume":"81","author":"Morath","year":"2016","journal-title":"Int J Biochem Cell Bio"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/carcin\/bgu243","article-title":"Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target","volume":"36","author":"Jackson","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0029","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3892\/etm.2013.1069","article-title":"Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes","volume":"5","author":"Cheng","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/genes12081289","article-title":"MiRNAs and Cancer: Key Link in Diagnosis and Therapy","volume":"12","author":"Shi","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.arcmed.2022.08.003_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112187","article-title":"Regulatory interplay between microRNAs and WNT pathway in glioma","volume":"143","author":"Tabnak","year":"2021","journal-title":"Biomed Pharmacother"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:51:22Z","timestamp":1759261882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440922000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0188440922000959"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.08.003","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-373\/miR-520s-CD44 Axis Significantly Inhibits the Growth and Invasion of Human Glioblastoma Cells","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}